AGI-14100
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Product Specifications
CAS Number
1448346-43-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
599.96
Molecular Formula
C29H22ClF4N5O3
Notes
Research use only, not for human use.
Receptor
Dehydrogenase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EKC2227 1 Kit, Containing two 96 Well Plates and all necessary reagents
Caspase 3 (Phospho-Ser150) Colorimetric Cell-Based ELISA Kit
Sign In for Pricing
View Details 
041448-FITC 200 µL
SCAP, NT (SCAP, KIAA0199, Sterol regulatory element-binding protein cleavage-activating protein) (FITC) discontinued
Sign In for Pricing
View Details LV727247 1.0 µg DNA
H2AFZP6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
PB9242-Dylight488 100 µg
Anti-Fetuin A/AHSG Antibody Picoband® (Dylight488 Conjugate)
Sign In for Pricing
View Details